2021-08-13T09:39:20-05:00 2020-09-30 861065772 Deloitte Tax LLP 695 Town Center Drive Suite 1000 Costa Mesa CA 92626 990 2019-10-01 330435954 The Scripps Research Institute SCRI 8587841000 10550 North Torrey Pines Road La Jolla CA 92037 Jared Machado Chief Financial Officer 8587841000 2021-08-13 1 John Sadoff Jr P00540589 7144367100 2019 2022-09-23 18:48:47Z Peter Schultz 10550 North Torrey Pines Road La Jolla CA 92037 466682291 0 X www.scripps.edu X 1924 CA TSRI conducts biomedical and biochemical research and postgraduate training programs. 16 14 2199 12 -94497 -121467 366278398 361859000 2851883 2222378 15672880 22451990 27380820 28313244 412183981 414846612 15022351 14124814 0 0 200866661 204838315 52468 2492 4589330 216656487 225038263 432597967 444003884 -20413986 -29157272 962297107 973580297 281456307 321951842 680840800 651628455 X The Scripps Research Institute ("TSRI") performs high impact basic biomedical research, improves the human condition by fostering translation of its discoveries into useful products and engages in the highest quality graduate scientific education and post graduate scientific training. TSRI is known for its entrepreneurial environment and its emphasis in research relating to synthetic chemistry, the relationship between molecular structure and activity and chemical biology. 0 0 389297496 2222378 Groundbreaking scientific research is conducted at TSRI campuses in La Jolla, California, and Jupiter, Florida, supported by grants, contracts and fellowships from public and private institutes and individuals. TSRI's unique structure merges basic scientific studies in biology, chemistry and bioinformatics with translational science to produce the next generation of drugs and advances in digital and precision medicine. Scientific discoveries at TSRI seed joint drug discovery projects at Calibr, a division of TSRI, creating a pipeline of drug candidates that will impact patients for years to come. The Scripps Research Translational Institute, another division of TSRI, aims to individualize healthcare by leveraging the progress being made in human genomics and combining it with the power of wireless digital technologies and artificial intelligence. 25429110 14124814 TSRI is committed to educating, training and inspiring the scientists of tomorrow. The Institute's Skaggs Graduate School of Chemical and Biological Sciences, ranked one of the ten best graduate programs in the country, empowers students to make high-impact discoveries at the interface of chemistry and biology. Students in the Skaggs Graduate School are immersed in intensive laboratory research from day one and pursue ambitious investigations across scientific disciplines. Graduates of the school become educators at top universities and research institutes, thought leaders within government departments and innovators at pharmaceutical and biotechnology companies. Postdoctoral associates arrive at TSRI from all over the globe, seeking to expand their knowledge and training by working alongside our world-renowned scientists. The Scripps Fellows program identifies individuals with an outstanding record of graduate research and moves them into their own laboratories, allowing them to leapfrog their postdoctoral years of study and begin pushing the frontiers of scientific discovery. 414726606 1 1 0 1 0 0 0 0 0 1 1 1 0 0 1 0 1 0 0 0 1 1 0 0 1 0 0 0 1 1 1 0 1 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 0 0 1 358 0 1 2199 1 1 1 0 0 0 0 1 1 0 0 0 0 0 0 0 X 16 14 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 AK AL CA CO DC FL GA HI IL KS KY MA MD MI MN MS NC NH NJ NM NY OH OR PA RI SC TN UT VA WI WV X Alice Feng 8587841000 3301 North Torrey Pines Court La Jolla CA 92037 Peter G Schultz President/CEO 40.00 0.00 X X 898378 0 71665 Eric Topol Professor/Exec VP 40.00 0.00 X 859147 0 69728 Matthew Tremblay Chief Operating Officer 40.00 0.00 X 677484 0 62901 James R Williamson VP Rsch & Academic Affairs 40.00 0.00 X 409632 0 71300 Jared M Machado Treasurer/Chief Accounting Officer 40.00 0.00 X 393518 0 75528 Vadim Klyushnichenko VP Pharmaceutical Dev & Qual 40.00 0.00 X 392087 0 61277 Alice T Feng CFO 40.00 0.00 X 393905 0 56439 Jennifer Crosby VP Philanthropy 40.00 0.00 X 372321 0 75088 Jeffrey Kelly Director/Professor 40.00 0.00 X 372601 0 70455 Kevin Eastwood Strategic Ptnrshp, Sr.Dir. 40.00 0.00 X 377023 0 58730 Douglas A Bingham Secretary/EVP Scripps Fl 40.00 0.00 X 350312 0 69355 Peter K Vogt Professor/Former Exec VP 40.00 0.00 X 315557 0 70335 Jim C Paulson Professor/Former Interim President 40.00 0.00 X 304193 0 72440 Emily Holmes VP OPERA 40.00 0.00 X 353365 0 22142 Demetrios I Andrikos Secretary/VP Legal & General Counsel 40.00 0.00 X 299006 0 74736 Mary Wang Assistant Secretary 40.00 0.00 X 148987 0 24452 Benedict Gross Director 1.00 0.00 X 0 0 0 Bernard Saint-Donat PhD Director 1.00 0.00 X 0 0 0 Christopher T Walsh Director 1.00 0.00 X 0 0 0 Claudia S Luttrell Director 1.00 0.00 X 0 0 0 Ge Li Director 1.00 0.00 X 0 0 0 Gerald Chan Director 1.00 0.00 X 0 0 0 Isy Goldwasser end 070520 Director 1.00 0.00 X 0 0 0 Joel S Marcus end 051520 Director 1.00 0.00 X 0 0 0 John D Diekman Board Chair 1.00 0.00 X 0 0 0 John Martin Director 1.00 0.00 X 0 0 0 Mark Edwards Director 1.00 0.00 X 0 0 0 Mark Pearson Director 1.00 0.00 X 0 0 0 Peter C Farell PhD D Sc Director 1.00 0.00 X 0 0 0 Ron Burkle Director 1.00 0.00 X 0 0 0 Sherry Lansing Director 1.00 0.00 X 0 0 0 William R Hearst III Director 1.00 0.00 X 0 0 0 6917516 0 1006571 325 1 1 1 Cooley LLP 101 California St 5th floor San Francisco CA 94111 Legal Services 1036314 Wilson Sonsini Goodrich & Rosati PO Box 742866 Los Angeles CA 90074 Legal Services 688967 Deloitte & Touche LLP PO BOX 844708 Dallas TX 75284 Audit & Tax Services 603964 Hogan Lovells US LLP 600 Brickell Ave Suite 2700 Miami FL 33131 Legal Services 363855 Schwegman Lundberg Woessner PA 121 South Eight Street Minneapolis MN 55402 Legal Services 298699 15 53137 243501564 118304299 4348925 361859000 Patent Office 900099 2222378 2222378 2222378 5819892 -94497 5914389 26628349 26628349 680953 738704 -57751 -57751 -57751 67701344 7705 50935052 141899 16766292 -134194 16632098 16632098 20024 53137 20024 0 Shared Srvcs-Scripps H 900099 477325 477325 1265321 1265321 1742646 414846612 2222378 -94497 50859731 X 13012232 13012232 1112582 1112582 4294526 1488956 2805570 157591254 147027300 8466946 2097008 -85607 -79063 -5518 -1026 31248037 29557376 1340610 350051 11790105 10888848 759895 141362 10482 10482 2492 2492 111149780 108677347 1804064 668369 3261626 2917403 156637 187586 10149756 8443842 1613466 92448 2446145 2311450 94680 40015 2019208 2019208 29510230 29506601 3629 3114435 2318440 4991 791004 Lab Supplies 29489608 25467113 3855958 166537 Professional Services 23517942 19489026 3790649 238267 Utilities 11241949 10691657 550292 Disposal of Equipment -134194 -134194 -738704 -738704 444003884 414726606 24687948 4589330 82702358 98947927 68183652 63831920 595679 551089 852107 1105159 25068259 26023324 799280597 492351845 311453912 306928752 245761820 234582399 222581626 236717854 832857 681429 4264837 4210444 962297107 973580297 49134538 59137780 131542625 165535637 30333402 27535797 39330000 38485000 31115742 31257628 281456307 321951842 X 456691979 414325811 224148821 237302644 680840800 651628455 962297107 973580297 X -29157272 -55069 -4 X 0 1 X 1 1 1 X 323083434 315969113 347588971 366278398 361859000 1714778916 323083434 315969113 347588971 366278398 361859000 1714778916 1714778916 12773043 14626349 22130806 36426682 33129194 119086074 0 0 0 0 0 2255567 1202834 1329949 978397 1742646 7509393 1841374383 12987367 0.93120 X Schedule A, Part II, Line 10, Explanation of Other Income: Other Income - 2015 Amount: $ 2,255,567. 2016 Amount: $ 1,202,834. 2017 Amount: $ 1,329,949. 2018 Amount: $ 978,397. 2019 Amount: $ 1,742,646. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 0 0 0 0 0 0 1 10482 10482 0 Part II-B, Line 1: TSRI pays annual dues to the Association of Independent Research Institute (AIRI) and the National Association of College and University Business Officers (NACUBO), a portion of which is used for lobbying activities. TSRI also uses the services of KMarcus Research Group LLC for any governmental relations needs. TSRI does not participate in or intervene in (including the publishing or distributing of statements) any political campaign on behalf of (or in opposition to) any candidate for public office. 112171714 12416199 831736 1002022 124417627 99581986 13237745 361209 1009226 112171714 69583647 29168940 888030 58631 99581986 72652489 3182125 2132475 8383442 69583647 69296085 3512735 1291236 1447567 72652489 0.13000 0.87000 0.00000 0 0 43352136 43352136 449314094 242028728 207285366 22438066 21671893 766173 278604110 225235985 53368125 5572191 3415239 2156952 306928752 Investment in Limited Partnerships 236717854 F 236717854 Pension Liability 25191626 Leases Scheduled Rent 5783703 Unitrust 282299 31257628 415664441 -55069 872898 817829 414846612 0 414846612 444876782 872898 872898 444003884 0 444003884 Part V, Line 4: Investment return from the endowments supports scientific projects consistent with the mission and principles of The Scripps Research Institute. Part XI, Line 2d - Other Adjustments: Rental Expenses Netted Against Rental Revenue 738,704. Loss on Disposal of Equipment 134,194. Part XII, Line 2d - Other Adjustments: Rental Expenses Netted Against Rental Revenue 738,704. Loss on Disposal of Equipment 134,194. 1 Europe (Including Iceland & Greenland) 0 0 Program Services Grants for Scientific Research 740285 North America 0 0 Program Services Grants for Scientific Research 210667 Sub-Saharan Africa 0 0 Program Services Grants for Scientific Research 161630 Central America and the Caribbean 0 0 Investments 50257191 0 0 0 0 0 0 51369773 0 51369773 North America Grants for Scientific Research 94491 Check Europe (Including Iceland & Greenland) Grants for Scientific Research 201658 Check Sub-Saharan Africa Grants for Scientific Research 90760 Electronic fund/wire transfer Europe (Including Iceland & Greenland) Grants for Scientific Research 60466 Check Europe (Including Iceland & Greenland) Grants for Scientific Research 77250 Check North America Grants for Scientific Research 116176 Check Europe (Including Iceland & Greenland) Grants for Scientific Research 244805 Electronic fund/wire transfer Europe (Including Iceland & Greenland) Grants for Scientific Research 156106 Check Sub-Saharan Africa Grants for Scientific Research 70870 Check 9 0 1 0 1 0 1 0 Part I, line 3: TSRI monitors the amounts provided to the foreign organization by adherence to a grant contract and monitors detailed billing statements of research expenditures. Part III Accounting Method: Schedule F, Part IV: TSRI has less than 10% ownership in a foreign corporation during the tax year, and therefore, was not required to file Form 5471. WISE 23811 14617 9194 6446 2748 Food For Thought 49350 38520 10830 9016 1814 0 0 0 73161 53137 20024 15462 4562 20024 0 1 0 0 Scholarships & Stipends, TSRI Graduate School 419 13012232 Part I, Line 2: Graduate student stipends are processed via personnel action forms which are approved by the Graduate Office and Human Resources prior to being sent to the payroll office. Once approved, graduate students are set up in TSRI's payroll system and are dispersed on the 1st and 15th of each month. Monitoring is done via the interaction between the student and faculty advisor. As long as the student is progressing, she/he would continue to be paid. X X 1 1 X X X X 1 0 0 0 0 0 0 0 0 Peter G Schultz President/CEO 782852 0 79502 0 36024 0 56000 0 15665 0 970043 0 0 0 Eric Topol Professor/Exec VP 859147 0 0 0 0 0 56000 0 13728 0 928875 0 0 0 Matthew Tremblay Chief Operating Officer 496215 0 179667 0 1602 0 42000 0 20901 0 740385 0 0 0 James R Williamson VP Rsch & Academic Affairs 359972 0 36001 0 13659 0 56000 0 15300 0 480932 0 0 0 Jared M Machado Treasurer/Chief Accounting Officer 347179 0 35000 0 11339 0 56000 0 19528 0 469046 0 0 0 Vadim Klyushnichenko VP Pharmaceutical Dev & Qual 305409 0 84851 0 1827 0 42000 0 19277 0 453364 0 0 0 Alice T Feng CFO 230013 0 144253 0 19639 0 37979 0 18460 0 450344 0 0 0 Jennifer Crosby VP Philanthropy 328008 0 33003 0 11310 0 56000 0 19088 0 447409 0 0 0 Jeffrey Kelly Director/Professor 341986 0 0 0 30615 0 56000 0 14455 0 443056 0 0 0 Kevin Eastwood Strategic Ptnrshp, Sr.Dir. 300770 0 76253 0 0 0 42000 0 16730 0 435753 0 0 0 Douglas A Bingham Secretary/EVP Scripps Fl 279237 0 28001 0 43074 0 56000 0 13355 0 419667 0 0 0 Peter K Vogt Professor/Former Exec VP 292746 0 0 0 22811 0 56000 0 14335 0 385892 0 0 0 Jim C Paulson Professor/Former Interim President 277088 0 0 0 27105 0 56000 0 16440 0 376633 0 0 0 Emily Holmes VP OPERA 75495 0 0 0 277870 0 15623 0 6519 0 375507 0 0 0 Demetrios I Andrikos Secretary/VP Legal & General Counsel 269806 0 27502 0 1698 0 55511 0 19225 0 373742 0 0 0 Mary Wang Assistant Secretary 124985 0 24002 0 0 0 12579 0 11873 0 173439 0 0 0 Part I, Line 1a Business travel and first class travel. The Scripps Research Institute allows for business travel for certain key employees for long haul flights. In certain circumstances, business class service is not available on smaller aircraft. In those circumstances, TSRI allows first class travel. At times TSRI will relocate employees between campuses and will provide a housing allowance for a limited duration to assist with the transition, which was provided to Douglas A. Bingham, Executive Vice President of Scripps Florida. This was paid out based on an agreement with Mr. Bingham and not in accordance with a written policy. Part I, Line 4a The following individual received severance payments: Emily Holmes $238,340 Other Information Related to Form 990, Part VII, Line 5: Eric Topol, M.D., received compensation from an unrelated organization, Scripps Clinic Medical Group, for services provided to The Scripps Research Institute. In 2019, in exchange for these services, The Scripps Research Institute reimbursed the Scripps Medical Group $562,500 A California Infrastructure & Economic Development Bank 630304653 13034AMU1 2016-08-30 40511601 See Part VI 0 0 0 A 9210000 40511601 5109295 648704 35125321 2016 1 1 1 1 A 0 0 0 1 0 0.00000 0.00000 0.00000 0 0 1 A 0 1 0 0 0 0 0 1 A 1 Schedule K, Part I, Bond Issues: (a) Issue Name: California Infrastructure & Economic Development Bank (f) Description on Purpose: Refund and defease bonds previously issued for the benefit of the Institute on 06/29/2000 and 02/23/2005. Schedule K, Part III, Line 3d: Overall private use isn't material and outside counsel would review any significant agreements. Schedule K, Part IV, Line 6: This question is being answered without regard to a yield-restricted advance refunding escrow financed with proceeds of the bonds. Joel S Marcus Member of the Board of Directors 4591700 See Part V 0 Ge Li Member of the Board of Directors 3029819 See Part V 0 Sch L, Part IV, Business Transactions Involving Interested Persons: (a) Name of Person: Joel S. Marcus(b) Relationship Between Interested Person and Organization: Member of the Board of Directors - The Scripps Research Institute(c) Amount of Transaction $4,591,700.(d) Description of Transaction: The Scripps Research Institute (TSRI) leases office and laboratory space building from Alexandria Real Estate (ARE). Joel S. Marcus is the Executive Chairman & Founder of ARE. Mr. Marcus was appointed to TSRI'S Board as of May 2017. Lease commenced in November 1997, at which time, the property was not owned by ARE and Mr. Marcus was not a member of TSRI'S Board.(e) Sharing of Organization Revenues? = No(a) Name of Person: Ge Li(b) Relationship Between Interested Person and Organization: Member of the Board of Directors - The Scripps Research Institute(c) Amount of Transaction $3,029,819.(d) Description of Transaction: California Institute for BioMedical Research (CALIBR) a division of The Scripps Research Institute (TSRI) has contracts with outside parties for outsourced research services. Ge Li is the Chairman and Chief Executive Officer at Wuxi Companies which is one of the contracted parties to provide outsourced research services. CALIBR began working with Wuxi in 2013, at which time Mr. Li was not a member of TSRI or CALIBR's Board. Wuxi Companies and TSRI or Calibr do not share revenue.(e) Sharing of Organization Revenues? = No X 7 297734 Cost or Selling Price X 2 4051191 Cost or Selling Price 0 0 1 1 Part I, Column (b): Securities - Publicly traded - No. of contributions Real Estate - Residential - No. of items contributed Part I, Line 32b: Shares of stock gifted to TSRI are transferred into our brokerage account at Morgan Stanley and they in turn sell the shares and wire proceeds to TSRI. Form 990, Part VI, Section B, line 11b On June 24, 2021, the Audit Committee reviewed a draft of the Form 990 (including all supplemental schedules). This review included a presentation of the statements by the Chief Financial Officer with particular emphasis on disclosures about governance and about transactions with interested persons. The 990 will be provided to the full Board of Directors prior to filing. Form 990, Part VI, Section B, line 12c TSRI'S Conflict of Interest Policies and Procedures apply to members of the Board of Directors, officers, key personnel, and their family members (altogether covered individuals) to protect the interests of TSRI when it is contemplating entering into a transaction or arrangement that could: 1) Benefit the private interest of a covered individual within the meaning of Treasury Regulation Section 1.501(c)(3)-1(d)(1)(ii), 2) Result in a possible excess benefit transaction within the meaning of Section 4958(c) of the Internal Revenue Code of 1986, as amended; or 3) Be a self-dealing transaction within the meaning of Section 5233 of the California Corporations Code (the "Corporations Code"). TSRI's policies and procedures are intended to supplement, but not replace, any state and federal laws governing actual, potential, or apparent conflict of interest applicable to TSRI. Disclosure documents responsive to TSRI's policies are annually submitted by covered individuals, and are reviewed by TSRI administration for pertinent relationships. Any transactions or arrangements involving covered individuals that fall within the scope of the policies are then subject to review and consideration by non-conflicted Board of Director members, with conflicted members being recused from any debate and vote to approve or disapprove. Form 990, Part VI, Section B, line 15 The compensation of the CEO and certain other key executives was reviewed and approved by the Board of Directors. This review was based, in part, on analysis performed by the Human Resources department, and included data from outside consultants or internally-conducted research. On an ongoing basis, executives may participate in the normal annual salary increase program, which is based on a recommendation from the Human Resources department based on market research. Any unusual or potentially non-qualified compensation would be reviewed by outside counsel for any tax compliance issues. Form 990, Part VI, Section C, line 19 Governing documents and Conflict of Interest Policies are not available to the public at this time. The financial statements are filed with the State of Florida by The Scripps Florida Funding Corporation. The statements are provided to bond holders through TSRI's dissemination agent. The annual information return is provided upon request. Form 990, Part IX, line 11g Purchases Services and Maintenance: Program service expenses 108,677,347. Management and general expenses 1,804,064. Fundraising expenses 668,369. Total expenses 111,149,780. Form 990, Part XI, line 9: Rounding -4. STRIDE LLC 10550 North Torrey Pines Rd La Jolla CA 92037 825129385 Facilitate Basic Research CA 202550 59473 The Scripps Research Institute Calm Therapeutics Inc 10550 North Torrey Pines Rd La Jolla CA 92037 825375039 Research DE The Scripps Research Institute C -146609 195127 0.62020 1 Biosurf Inc 10550 North Torrey Pines Rd La Jolla CA 92037 825117568 Research DE The Scripps Research Institute C -1262 700 0.60600 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 Calm Therapeutics Inc L 262023 Cash Method